UNC Hospitals
Locations
Transplant Summary
Overview
Formed in 1992, UNC is a FACT-accredited transplant program affiliated with the NCI-designated Lineberger Comprehensive Cancer Center. We provide a multidisciplinary team approach to related/unrelated allogeneic and autologous transplant candidates for children and adults with a variety of hematologic/solid tumor diseases.This center has been performing allogeneic transplants since 1993 and has been an NMDP transplant center since December 1995.
Attending physicians
Adult - Paul Armistead, James Coghill, Katarzyna Jamieson, Jeremy Meier, Jonathan Serody, Anson Snow, Astha Thakkar, Ben Vincent, William Wood
Pediatric - George Hucks, Kimberly Kasow, Michael WinsteadTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
Our Bone Marrow Transplant and Cellular Therapy Program is a comprehensive adult and pediatric program that is FACT accredited for both autologous and allogeneic transplants. We have discounted housing available within a few miles of campus through our SECU Family House (http://www.secufamilyhouse.org) and The Ronald McDonald House of Chapel Hill (http://rmh-chapelhill.org). Our patients receive personalized care throughout the BMT process with a dedicated team of BMT physicians, Advanced Practice Providers (APPs) and specifically assigned Transplant Nurse Coordinators. Your care team also includes BMT-specific RNs, Social Workers, Nutritionists, Clinical Pharmacist Practitioners, Recreational Therapists, Child Life Therapists and School Teachers. Our Comprehensive Cancer Support Program (CCSP) (https://unclineberger.org/patientcare/support/ccsp) is dedicated to helping patients and their caregivers with cancer treatment, recovery and survivorship by providing compassionate and effective care for all cancer patients and their families. We are proud to also offer individualized AYA cancer support for adolescent and young adult patients facing a cancer diagnosis (https://uncaya.org) . The program brings together experts from different professions and areas of expertise to bring you and your loved ones the help you need.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 167 patients.The actual 1-year survival of these patients is 81.4%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 71.7% and 83.7%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
311
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow2PBSC35Cord blood0Total37Unrelated donorMarrow4PBSC60Cord blood0Total64Total allogeneicMarrow6PBSC95Cord blood0Total101AutologousMarrowBoth marrow & PBSC 210PBSC—Cord blood—Total210Total combinedMarrowBoth marrow & PBSC 311PBSC—Cord blood0Total311Total pediatric transplants
30
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow14PBSC0Cord blood0Total14Unrelated donorMarrow6PBSC0Cord blood3Total9Total allogeneicMarrow20PBSC0Cord blood3Total23AutologousMarrowBoth marrow & PBSC 7PBSC—Cord blood—Total7Total combinedMarrowBoth marrow & PBSC 27PBSC—Cord blood3Total30All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-181619-44845-641965+8Total51Unrelated 0-18919-441845-641865+28Total73Autologous 0-18719-444545-6410565+60Total217Total 0-183219-447145-6414265+96Total341Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinatorKaitlyn LogsdonPhone: 984-215-5119NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
No survivorship program information is available. Contact the center for information about post-transplant care.